Learn how Rome V criteria and gut–brain insights clarify pediatric constipation vs IBS-C, reducing unnecessary tests and guiding targeted pain care.

Learn how realistic expectations, long-term laxative plans, and shared goals improve pediatric constipation and IBS outcomes, reducing relapse anxiety

FDA expands linaclotide use for pediatric IBS-C, offering child-specific evidence to treat pain, bloating, and constipation beyond laxatives.

Validate families, reset expectations, and use shared decisions to manage pediatric constipation and IBS with personalized, functional goals.

Learn how validating families and treating pediatric IBS/constipation as gut–brain disorders boosts adherence and focuses care on daily life.